|Table of Contents|

IFN-γ and tumor immunity

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2021 01
Page:
143-148
Research Field:
Publishing date:

Info

Title:
IFN-γ and tumor immunity
Author(s):
SONG YunlaiZHU YueyiZHOU YiSHI Xiaolan
Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China.
Keywords:
interferon-gammamalignant tumornatural killer cellT cell
PACS:
R730.51
DOI:
10.3969/j.issn.1672-4992.2021.01.033
Abstract:
Malignant tumors (hereinafter referred to as tumors) are one of the most important causes of human death worldwide.Their characteristics of easy metastasis and high recurrence result in tens of millions of people losing their lives every year.In recent years,it has been found that the immune system of the body restricts the generation,metastasis and recurrence of tumors.In the microenvironment of tumors,cytokines secreted by various immune cells,such as interferon-gamma,play a key role in anti-tumour and immune regulation.As one of them,IFN-γ is indispensable in immune response and has become the main research object.Following is a review of recent advances in tumor immunity based on IFN-gamma.

References:

[1]徐燕,王孟昭.非小细胞肺癌免疫治疗进展[J].中国肺癌杂志,2014,17(01):34-41. XU Y,WANG MZ.Progress in immunotherapy of non-small cell lung cancer[J].Chinese Journal of Lung Cancer,2014,17(01):34-41.
[2]胡晓霞,李毅,熊琳.IL-17与IFN-γ在尖锐湿疣免疫发病机制中的作用研究[J].重庆医学,2018,47(32):4202-4204. HU XX,LI Y,XIONG L.Study on the role of IL-17 and IFN-γ in the immunopathogenesis of condyloma acuminatum[J].Chongqing Medicine,2018,47(32):4202-4204.
[3]姚天琦,王伏生,路晓庆,等.干扰素-γ在肿瘤免疫中的双重作用[J].中国药物与临床,2018,18(04):544-547. YAO TQ,WANG FS,LU XQ,et al.Dual role of interferon-γ in tumor immunity[J].Chinese Medicine and Clinic,2018,18(04):544-547.
[4]JEREMIAH LO,SARAH BG,DEBORAH AA,et al.PD-L1 blockade enhances anti-tumor efficacy of NK cells[J].Oncoimmunology,2018,7(11):e1509819.
[5]STORNAIUOLO G,CUNIATO V,CUOMO G,et al.Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infection[J].Dig Liver Dis,2014,46(1):62-66.
[6]MILLAR NL,O'DONNELL,CHARLOTTE,et al.Wounds that heal and wounds that don't:The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis[J].Seminars in Cell & Developmental Biology,2017,61:41-50.
[7]REZVANI K,ROUCE R,LIU E,et al.Engineering natural killer cells for cancer immunotherapy[J].Mol Ther,2017,25(8):1769-1781.
[8]YAMASHITA K,HASEGAWA H,FUJITA M,et al.Host CD40 is essential for DCG treatment against metastatic lung cancer[J].Anticancer Res,2016,36(7):3659-3665.
[9]CHEN J,WU M,WANG J,et al.Immunoregulation of NKT cells in systemic lupus erythematosus[J].J Immunol Res,2015,2015:1-8.
[10]SANDERS NL,MISHRA A.Role of interleukin-18 in the pathophysiology of allergic diseases[J].Cytokine Growth Factor Rev,2016,32:31-39.
[11]NELLES ME,PAIGE CJ.CD4+T cell plasticity engenders robust immunity in response to cytokine therapy[J].Oncoimmunology,2015,4(3):e994370-1.
[12]BI J,WANG J,ZHOU K,et al.Synthesis and biological activities of 5-thio-alpha-galcers[J].ACS Med Chem Lett,2015,6(4):476-480.
[13]LIU RY,ZHU YH,ZHOU L,et al.Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma[J].J Transl Med,2012,10:256.
[14]GARCIA-TUNóN I,RICOTE M,RUIZ AA,et al.Influence of IFN-gamma and its receptors in human breast cancer[J].BMC Cancer,2007,7(1):158.
[15]LUO X,XIONG X,SHAN Q,et al.The tumor suppressor interferon regulatory factor 8 inhibits beta-catenin signaling in breast cancers,but is frequently silenced by promoter methylation[J].On Cotarget,2017,8(30):48875-48888.
[16]MA Z,QIN H,BENVENISTE EN,et al.Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β:Critical role of STAT-1α[J].J Immunol,2001,167(90):5150-5159.
[17]LIMA TS,LODOEN MB.Mechanisms of human innate immune evasion by toxoplasma gondii[J].Frontiers in Cellular and Infection Microbiology,2019,9:103.
[18]MOREY PAU,MEYER TF.The sweeping role of cholesterol depletion in the persistence of helicobacter pylori infections[J].Current Topics in Microbiology and Immunology,2019,421:209-227.
[19]NING YJ,MO Q,FENG K,et al.Interferon-γ-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1[J].Frontiers in Immunology,2019,10:1182.
[20]宁红娟,杨小花.吉西他滨联合卡铂对肺癌患者血清IL-2、IFN-γ、TNF-α与IGF-1水平的影响[J].实用癌症杂志,2018,33(12):2008-2010. NING HJ,YANG XH.The effect of gemcitabine combined with carboplatin on the serum levels of IL-2,IFN-γ,TNF-α and IGF-1 in patients with lung cancer[J].Journal of Practical Cancer,2018,33(12):2008-2010.
[21]宋佳敏,王鸿飞,罗洁,等.金蝉花多糖对小鼠免疫功能的影响[J].核农学报,2018,32(10):1977-1983. SONG JM,WANG HF,LUO J,et al.Effect of polysaccharide from cicada flower on immune function of mice[J].Journal of Nuclear Agriculture,2018,32(10):1977-1983.
[22]黎翠翠,陈曲波.肿瘤微环境中Th17细胞生物学特性的研究进展[J].广东医学,2010,31(17):2328-2331. LI CC,CHEN QB.Research progress in biological characteristics of Th17 cells in tumor microenvironment[J].Guangdong Medicine,2010,31(17):2328-2331.
[23]DANGAJ D,BRUAND M,GRIMM AJ,et al.Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors[J].Cancer Cell,2019,35(6):885.
[24]BOUSSIOTIS VA.Molecular and biochemical aspects of PD-1 checkpoint pathway[J].N Engl J Med,2016,375(18):1767-1778.
[25]LO PRESTI E,DIELI F,MERAVIGLIA S.Tumor-infiltrating gammadelta T lymphocytes:pathogenic role,clinical significance,and differential programing in the tumor microenvironment[J].Front Immunol,2014,5:607.
[26]ASHRAFI S,SHAPOURI R,MAHDAVI M.Immunological consequences of immunization with tumor lysatevaccine and propranolol as an adjuvant:A study on cytokine profiles in breast tumor microenvironment[J].Immunology Letters,2017,181:63-70.
[27]隋洪涛,张彩华,宋文军,等.DC细胞疫苗干预肝癌Treg细胞及与IDO、IFN-γ等细胞因子相关性[J].贵州医药,2018,42(10):1173-1176. SUI HT,ZHANG CH,SONG WJ,et al.Effects of DC cell vaccine on Treg cells and its correlation with IDO,IFN-γ and other cytokines[J].Guizhou Medicine,2018,42(10):1173-1176.
[28]MORI K,HARAGUCHI S,HIORI M,et al.Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment[J].Bmc Cancer,2015,15(1):1-11.
[29]DILLINGER B,AHMADI-ERBER S,LAU M,et al.IFN-gamma and tumor gangliosides:Implications for the tumor microenvironment[J].Cellular Immunology,2018,325:33-40.
[30]MAJOROS A,PLATANITIS E,KERNBAUER-HOLZL E,et al.Canonical and non-canonical aspects of JAK-STAT signaling:Lessons from interferons for cytokine responses[J].Frontiers in Immunology,2017,8:29.
[31]CHATTERJEE-KISHORE M,WRIGHT KL,TING JP,et al.How Stat1 mediates constitutive gene expression:acomplex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene[J].The EMBO Journal,2000,19(15):4111-4122.
[32]MURTAS D,MARIC D,DE GIORGI V,et al.IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes[J].British Journal of Cancer,2013,109(1):76-82.
[33]MATTHEW FK,JAGDISH NM,LION FU,et al.Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation[J].Proc Natl Acad Sci USA,2018,115(45):11585-11590.
[34]SUCKER A,ZHAO F,PIEPER N,et al.Acquired IFN-γ resistance impairs anti-tumor immunity andgives rise to T-cell-resistant melanoma lesions[J].Nature Communications,2017,8:15440.
[35]AKIMITSU M,YOSHIKO I,HITOMI S,et al.IL-11 prevents IFN-γ induced hepatocyte death through selective downregulation of IFN-γ/STAT1 signaling and ROS scavenging[J].PLoS One,2019,14(2):e0211123.
[36]PATEL SJ,SANJANA NE,KISHTON RJ,et al.Identification of essential genes for cancer immunotherapy[J].Nature,2017,548(7669):537-542.
[37]AKIKO Y,RIEKO A,MASAKO S,et al.Dual role of Fas/FasL-mediated signal in peripheral immune tolerance[J].Frontiers in Immunology,2017,8:403.
[38]SHIGEO M,YOUSUKE T,MASANORI K,et al.The immunoproteasome and thymoproteasome:functions,evolution and human disease[J].Nature Immunology,2018,19(9):923-931.
[39]LEE JW,OH JE,RHEE KJ,et al.Co-treatment with interferon-γ and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis[J].Molecular and Cellular Biochemistry,2019,458(1):197-205.
[40]TORI NY,LEE PH,SUMAN KV,et al.T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy[J].J Clin Invest,2019,129(4):1551-1565.
[41]SHEN YY,SONG ZB,LU XL,et al.Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions[J].Nat Commun,2019,10:2924.
[42]AYERS M,LUNCEFORD J,NEBOZHYN M,et al.IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade[J].The Journal of Linical Investigation,2017,127(8):2930-2940.
[43]KARACHALIOU N,GONZALEZ-CAO M,CRESPO G,et al.Interferon gamma,an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients[J].Therapeutic Advances in Medical Oncology,2018,10:175883401774974.
[44]MO X,ZHANG H,PRESTON S,et al.Interferon-gamma signaling in melanocytes and melanoma cells regulates expression of CTLA-4[J].Cancer Research,2018,78(2):436-450.
[45]DONG HK,HYEONGRYUL K,YUN JC,et al.Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer[J].Exp Mol Med,2019,51(8):94.
[46]LI YM,YU JM,LIU ZY,et al.Programmed death ligand 1 indicates pre-existing adaptive immuneresponse by tumor-infiltrating CD8+T cells in non-small cell lung cancer[J].International Journal of Molecular Sciences,2019,20(20):5138.
[47]DANGAJ D,BRUAND M,GRIMM,et al.Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors[J].Cancer Cell,2019,35(6):885.
[48]NAGARSHETH N,PENG D,KRYCZEK I,et al.PRC2 epigenetically silences Th1-type chemokines to suppress effector T-cell trafficking in colon cancer[J].Cancer Research,2016,76(2):275-282.
[49]QIAN JW,WANG C,WANG B,et al.The IFN-γ/PD-L1 axis between T cells and tumor microenvironment:Hints for glioma anti-PD-1/PD-L1 therapy[J].J Neuroinflammation,2018,15:290.
[50]SALERNO F,GUISLAIN A,FREEN-VAN HJJ,et al.Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells[J].Oncoimmunology,2018,8(2):1-12.
[51]GORDON-ALONSO M,HIRSCH T,WILDMANN C,et al.Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration[J].Nature Communications,2017,8(1):793.
[52]ZARETSKY JM,GARCIA-DIAZ A,SHIN DS,et al.Mutations associated with acquired resistance to PD-1 blockade in melanoma[J].New England Journal of Medicine,2016,375(9):819-829.
[53]SHIN DS,ZARETSKY JM,ESCUIN-ORDINAS H,et al.Primaryresistance to PD-1 blockade mediated by JAK1/2 mutations[J].Cancer Discovery,2017,7(2):188-201.
[54]LI XL,SHANG BX,LI YN,et al.IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide[J].Stem Cell Res Ther,2019,10:18.
[55]ERIGUCHI Y,NAKAMURA K,YOKOI Y,et al.Essential role of IFN-γ in T cell-associated intestinal inflammation[J].JCI Insight,2018,3(18):pii:121886.
[56]JIANG XF,WU H,ZHAO W,et al.Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells[J].Cancer Cell Int,2019,19:68.
[57]OVERACRE-DELGOFFE AE,CHIKINA M,DADEY RE,et al.Interferon-gamma drives Treg fragility to promote anti-tumor immunity[J].Cell,2017,169(6):1130.
[58]DING GP,SHEN T,YAN C,et al.IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+T-lymphocytes in pancreatic cancer[J].BMC Cancer,2019,19:1053.
[59]许瑶琳.小细胞肺癌中IFN-γ诱导肿瘤表面免疫检查点 PD-L1/CD155/Galectin-9高表达的机制研究[D].沈阳:中国医科大学,2018. XU YL.Study on the mechanism of high expression of PD-L1/CD155/galectin-9 induced by IFN-γ in small cell lung cancer[D].Shenyang:China Medical University,2018.
[60]THIJS SS,ARJAN K,ELISABETH GDV,et al.MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells[J].J Pathol,2019,249(1):52-64.
[61]邓菲丹,罗建业.结肠癌组织IL-10和IFN-γ mRNA的表达及其临床意义[J].中国医学创新,2015,12(14):60-63. DENG FD,LUO JY.Expression of IL-10 and IFN-γ mRNA in colon cancer and its clinical significance[J].Chinese Medical Innovation,2015,12(14):60-63.
[62]BAITSCH L,BAUMGAERTNER P,ESTELLE D,et al.Exhaustion of tumor-specific CD8+T cells in metastases from melanoma patients[J].Journal of Clinical Investigation,2011,121(6):2350-2360.
[63]GAO X,ZHU Y,LI G,et al.TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression[J].Plos One,2012,7(2):e30676.
[64]SAKUISHI K,APETOH L,SULLIVAN JM,et al.Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity[J].Journal of Experimental Medicine,2010,207(10):2187-2194.
[65]MEHTA SY,MORTEN BC,ANTONY J,et al.Regulation of the interferon-gamma(IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes[J].Oncotarget,2018,9(49):29146-29161.
[66]ZHOU L,SHEN T.IFN-γ induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells:A novel mechanism for IFN-γ response[J].Oncology Letters,2018,15(3):3760-3765.
[67]BANZOLA I,MENGUS C,WYLER S,et al.Expression of indoleamine 2,3-dioxygenase induced by IFN-γ and TNF-α as potential biomarker of prostate cancer progression[J].Frontiers in Immunology,2018,9:1051.
[68]LI L,JAY SM,WANG Y,et al.IL-12 stimulates CTLs to secrete exosomes capable of activating by stander CD8+T cells[J].Scientific Reports,2017,7(1):13365.
[69]HUANG RQ,WU JM,ZHOU XS,et al.Herpes simplex virus 1 microRNA miR-H28 exported to uninfected cells in exosomes restricts cell-to-cell virus spread by inducing gamma interferon mRNA[J].Journal of Virology,2019,93(21):pii:e01005-19.
[70]JIANG L,LIU JY,SHI Y,et al.MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling[J].J Exp Clin Cancer Res,2019,38(1):206.
[71]WANG WM,MICHAEL G,JAE EC,et al.CD8+T cells regulate tumor ferroptosis during cancer immunotherapy[J].Nature,2019,569(7755):270-274.

Memo

Memo:
上海市卫生和计划生育委员会科研课题(编号:201640073);上海市普陀区卫生系统自主创新科研资助项目(编号:ptkwws201804)
Last Update: 2020-11-30